Delivery Order SPE2DB20D2104-SPE2DB25FMPRW
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,772.00 delivery order contract is for the supply of 4,565,675,754 units of the generic drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of September 5, 2024. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,854.22 firm fixed-price delivery order is for the supply of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of September 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,697.77 to provide 1,000 units of the generic pharmaceutical drug Tamsulosin HCl 0.4 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,959.15 firm-fixed-price delivery order is for the supply of 1,000 units of the drug Tamsulosin HCl 0.4 mg capsules, with a completion date of April 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,850.87, is for the delivery of 4,566,871,083 units of the generic drug Tamsulosin HCl 0.4 mg capsules. This is a firm fixed-price delivery order contract with a completion date of January 9, 2025. The contract has no set-aside designation, indicating it was competed openly. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,775.78 Firm Fixed Price Delivery Order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.74 firm fixed-price delivery order is for the supply of 4,567,068,730 capsules of the generic drug Tamsulosin HCL 0.4 mg. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,244.34, is for the delivery of 4,567,678,476 units of Tamsulosin HCL 0.4 mg capsules. The contract is a firm fixed-price delivery order with a period of performance through March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The $4,297.74 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of December 12, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $1,902.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,310,884 capsules of Tamsulosin HCL 0.4 mg. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...